Company / Operating Cash Flow per Share
Bausch & Lomb Corp Operating Cash Flow per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$0.80
FY2025
5-year range
-$0.05 / $2.49
FY2021-FY2025
Trend
+21.2%
vs FY2024
Sector context
#117 of 155
Health Care
What the data says
Bausch & Lomb Corp's operating cash flow per share of $0.80 is lower than 75% of companies in the Health Care sector (FY2025). Improved from $-0.05 to $0.80 over the past 2 years.
Based on SEC 10-K filings.
0.80 in FY2025 with a 5-year CAGR of -11.6%.
Improved from $-0.05 to $0.80 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -6.6%
- 5-Year CAGR
- -11.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 155This company $0.80 Sector average $6.77
▼
-88.1% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 21.2% year-over-year.
- Ranks #117 out of 155 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2021.
- Lowest operating cash flow per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.74 (distress zone, below 1.8 threshold)
- Negative profit margin: -6.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.80 | +21.2% |
| FY2024 | $0.66 | +1464.7% |
| FY2023 | -$0.05 | -104.9% |
| FY2022 | $0.99 | -60.5% |
| FY2021 | $2.49 | +67.2% |
| FY2020 | $1.49 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026